(Q57904490)
Statements
Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer (English)
0 references
November 2012
0 references
30
0 references
31
0 references
3841-3847
0 references